These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32207346)

  • 1. Stevens-Johnson Syndrome-Like Reaction After Exposure to Pembrolizumab and Recombinant Zoster Vaccine in a Patient With Metastatic Lung Cancer.
    Riano I; Cristancho C; Treadwell T
    J Investig Med High Impact Case Rep; 2020; 8():2324709620914796. PubMed ID: 32207346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pembrolizumab-Induced Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis in a Patient With Metastatic Cervical Squamous Cell Carcinoma: A Case Report.
    Robinson S; Saleh J; Curry J; Mudaliar K
    Am J Dermatopathol; 2020 Apr; 42(4):292-296. PubMed ID: 31567395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stevens-Johnson Syndrome Induced by Pembrolizumab in a Lung Cancer Patient.
    Haratake N; Tagawa T; Hirai F; Toyokawa G; Miyazaki R; Maehara Y
    J Thorac Oncol; 2018 Nov; 13(11):1798-1799. PubMed ID: 29885481
    [No Abstract]   [Full Text] [Related]  

  • 4. Pembrolizumab-induced Stevens-Johnson Syndrome with Severe Ocular Complications.
    Ryu S; Jun I; Kim TI; Seo KY; Kim EK
    Ocul Immunol Inflamm; 2022 Aug; 30(6):1533-1535. PubMed ID: 33826467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful rechallenge with pembrolizumab after case of progressive immunotherapy-related mucocutaneous eruption (PIRME), a Stevens-Johnson syndrome-like reaction.
    Shi CR; Shaughnessy M; Sehgal K; Clark JR; Reynolds KL; Toyohara J; Chen ST
    Int J Dermatol; 2023 Oct; 62(10):1292-1294. PubMed ID: 36628976
    [No Abstract]   [Full Text] [Related]  

  • 6. Pembrolizumab associated Stevens-Johnson syndrome with porokeratosis in a patient in the setting of primary hepatocellular carcinoma.
    Zhang J; Zhang P; Xu QY; Zhu YT; Chen W; Ji C
    Australas J Dermatol; 2022 Feb; 63(1):e71-e74. PubMed ID: 34463968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stevens-Johnson syndrome manifesting late in the course of pembrolizumab therapy.
    Hwang A; Iskandar A; Dasanu CA
    J Oncol Pharm Pract; 2019 Sep; 25(6):1520-1522. PubMed ID: 30086678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pembrolizumab-induced Toxic Epidermal Necrolysis in a Patient with Metastatic Esophageal Adenocarcinoma.
    Gallo Marin B; Oliva R; Kahn B; Borgovan T; Brooks BE; Massoud CM
    R I Med J (2013); 2022 Apr; 105(3):34-36. PubMed ID: 35349618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxic epidermal necrolysis associated with pembrolizumab.
    Cai ZR; Lecours J; Adam JP; Marcil I; Blais N; Dallaire M; Belisle A; Mathieu A
    J Oncol Pharm Pract; 2020 Jul; 26(5):1259-1265. PubMed ID: 31810421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nivolumab-associated Stevens-Johnson syndrome in a patient with lung cancer.
    Gracia-Cazaña T; Padgett E; Calderero V; Oncins R
    Dermatol Online J; 2021 Mar; 27(3):. PubMed ID: 33865285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pembrolizumab induced toxic epidermal necrolysis.
    Kumar R; Bhandari S
    Curr Probl Cancer; 2020 Apr; 44(2):100478. PubMed ID: 31122669
    [No Abstract]   [Full Text] [Related]  

  • 12. Pembrolizumab-Associated Stevens-Johnson Syndrome in a Patient With Metastatic Non-small Cell Lung Cancer: A Case Report.
    Sandhu M; Kc B; Bhandari J; Gambhir HS; Farah R
    Cureus; 2023 Jul; 15(7):e41439. PubMed ID: 37546048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Afatinib-associated Stevens-Johnson syndrome in an EGFR-mutated lung cancer patient.
    Doesch J; Debus D; Meyer C; Papadopoulos T; Schultz ES; Ficker JH; Brueckl WM
    Lung Cancer; 2016 May; 95():35-8. PubMed ID: 27040849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bullous drug reaction after pembrolizumab administration: two case reports].
    Golle L; Michl C; Kreft B
    Dermatologie (Heidelb); 2022 Dec; 73(12):959-964. PubMed ID: 35925211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Case of Guillain-Barré Syndrome and Stevens-Johnson Syndrome/Toxic Epidermal Necrosis Overlap After Pembrolizumab Treatment.
    Oguri T; Sasada S; Shimizu S; Shigematsu R; Tsuchiya Y; Ishioka K; Takahashi S; Oki K; Kimura Y; Seki R; Hirose S; Nakamura M
    J Investig Med High Impact Case Rep; 2021; 9():23247096211037462. PubMed ID: 34344201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stevens-Johnson Syndrome After Armodafinil Use.
    Holfinger S; Roy A; Schmidt M
    J Clin Sleep Med; 2018 May; 14(5):885-887. PubMed ID: 29734973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pembrolizumab-induced Stevens-Johnson syndrome in advanced squamous cell carcinoma of the lung: A case report and review of literature.
    Wu JY; Kang K; Yi J; Yang B
    World J Clin Cases; 2022 Jun; 10(18):6110-6118. PubMed ID: 35949835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Rare Case of Severe Stevens-Johnson Syndrome Triggered by Topical Ofloxacin.
    Shaw B; Madden M; Crespo A; Madruga M; Carlan SJ
    Am J Case Rep; 2023 Nov; 24():e941992. PubMed ID: 37952083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Fritsch PO; Sidoroff A
    Am J Clin Dermatol; 2000; 1(6):349-60. PubMed ID: 11702611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Rare Laryngeal Presentation of Stevens-Johnson Syndrome.
    Vittetoe KL; Landeen KC; Gelbard A
    Laryngoscope; 2021 Nov; 131(11):2519-2522. PubMed ID: 33942909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.